Metabolic reprogramming in adenomyosis: current evidence, biological mechanisms and therapeutic perspectives
Review
OA: gold
CC0
Abstract
Background Adenomyosis (AM) is a common reproductive disorder in which endometrial glands and stroma are present within the myometrium. Although endocrine, inflammatory, fibrotic and tissue-injury mechanisms are well described, the metabolic adaptations associated with lesion persistence, tissue repair and the uterine microenvironment are only beginning to be defined. At present, no metabolic biomarker has been validated for routine selection of AM treatment. Main body Recent human metabolomic, lipidomic, transcriptomic and functional studies indicate alterations in glycolysis, mitochondrial metabolism, lipid metabolism, redox regulation and ferroptosis-related pathways. Importantly, these changes are context dependent. Reduced glycolytic activity has been associated with impaired eutopic endometrial repair and heavy menstrual bleeding, whereas enhanced glycolysis has been reported in lesion-containing myometrium; increased cytochrome-c oxidase and ATP synthase content has also been reported in endometrial tissue from women with AM. Myometrial lipidomics and immune–metabolic analyses further support heterogeneous metabolic states. We evaluate how these alterations may interact with hypoxia, inflammation, fibrosis, angiogenesis and endocrine signalling while distinguishing direct AM evidence from inference derived from other disease models. We also examine whether traditional Chinese medicine (TCM) blood-stasis-related phenotypes can serve as clinically defined strata for prospective metabolic studies. Current evidence does not justify assigning any TCM syndrome to a specific metabolic pathway or treating these phenotypes as validated molecular subtypes. Finally, we discuss established hormonal treatment alongside emerging metabolism-related strategies, including metformin, glycolysis modulation, ferroptosis-related approaches, sphingosine-1-phosphate (S1P) signalling and TCM-derived interventions. Conclusions Metabolic reprogramming is an emerging component of AM biology, but the available evidence supports tissue- and phenotype-specific alterations rather than a single global metabolic state. A disease-wide statement such as “AM exhibits enhanced glycolysis” is insufficiently precise. Prospectively, compartment-resolved and flux-based studies are required before metabolic signatures can be translated into validated biomarkers or treatment-selection tools.
My notes (saved in your browser only)
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (88)
- Adenomyosis incidence, prevalence and treatment: United States population-based study 2006-2015 via openalex
- Adenomyosis in mice resulting from mechanically or thermally induced endometrial-myometrial interface disruption and its possible prevention via openalex
- Adenomyosis pathogenesis: insights from next-generation sequencing via openalex
- Altered VEGF, Bcl-2 and IDH1 expression in patients with adenomyosis via openalex
- Association of Uterine Tissue Innervation and Peripheral Nerve Density with Adenomyosis Related Pain. A Systematic Review via openalex
- Characterising the immune cell phenotype of ectopic adenomyosis lesions compared with eutopic endometrium: A systematic review via openalex
- Cracking the enigma of adenomyosis: an update on its pathogenesis and pathophysiology via openalex
- Cytochrome-c-oxidase and ATPsynthase content increases in the endometrium of the patients with adenomyosis via openalex
- Decoding apoptosis, ferroptosis, and inflammatory cell death in adenomyosis at single-cell resolution via openalex
- Decreased expression of GRIM-19 induces autophagy through the AMPK/ULK1 signaling pathway during adenomyosis† via openalex
- Decreased Glycolysis at Menstruation is Associated with Increased Menstrual Blood Loss via openalex
- Elevation of the phospholipase A2 activity in peritoneal fluid cells from women with endometriosis via openalex
- Enhanced glycolysis in the myometrium with ectopic endometrium of patients with adenomyosis: a preliminary study via openalex
- Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis via openalex
- Guideline No. 437: Diagnosis and Management of Adenomyosis via openalex
- Hypoxia and hypoxia inducible factor-1α are required for normal endometrial repair during menstruation via openalex
- Immunological changes associated with adenomyosis: a systematic review via openalex
- Immunometabolic profiling of cervicovaginal lavages identifies key signatures associated with adenomyosis via openalex
- Integrative metabolomic profiling reveals aberrations in myometrium associated with adenomyosis: a pilot study via openalex
- Lipidome atlas of human myometrium reveals distinctive lipid signatures associated with adenomyosis: Combination of high-coverage lipidomics and mass spectrometry imaging via openalex
- Long-term use of progestogens--effects on endometriosis, adenomyosis and myomas via openalex
- Mechanisms Underlying Adenomyosis-Related Fibrogenesis via openalex
- Meclizine improves endometrial repair and reduces simulated menstrual bleeding in mice with induced adenomyosis via openalex
- Metabolic changes in myometrium associated with adenomyosis revealed by liquid chromatography-tandem mass spectrometry-based high-throughput targeted lipid quantitative profiling via openalex
- Metformin inhibits growth of eutopic stromal cells from adenomyotic endometrium via AMPK activation and subsequent inhibition of AKT phosphorylation: a possible role in the treatment of adenomyosis via openalex
- METTL3-mediated m6A modification promotes ferroptosis in adenomyosis through GPX4 in a YTHDF1-dependent manner via openalex
- Myofibroblasts Are Evidence of Chronic Tissue Microtrauma at the Endometrial-Myometrial Junctional Zone in Uteri With Adenomyosis via openalex
- Oestrogen promotes the progression of adenomyosis by inhibiting CITED2 through miR-145 via openalex
- Paris polyphylla ethanol extract and polyphyllin I ameliorate adenomyosis by inhibiting epithelial-mesenchymal transition via openalex
- Proteomic Analysis of Uterine Tissues During Peri-Implantation Period in Mice with Experimentally Induced Adenomyosis that Treated with anti-Ngf: Implications for Cell-Cell Adhesion and Metabolic Processes via openalex
- Regulation on mitophagy in adenomyosis by Guizhi Fuling Wan via openalex
- Single-Cell Profiling Uncovers the Roles of Endometrial Fibrosis and Microenvironmental Changes in Adenomyosis via openalex
- Spatial and single-cell transcriptomics landscape of adenomyosis via openalex
- Spatial transcriptomics uncovers the hybrid molecular identity, ciliated phenotype, and immune signature of adenomyosis lesions via openalex
- Sphingosine 1-phosphate pathway is dysregulated in adenomyosis via openalex
- The endometriosis-adenomyosis spectrum: shared pathophysiology and microenvironment-driven disease divergence via openalex
- The interaction between inflammation and estrogen in adenomyosis : from molecular mechanisms to therapeutic strategies via openalex
- The use of dienogest in treatment of symptomatic adenomyosis: A systematic review and meta-analysis via openalex
- Tissue-predominant estrogen metabolic remodeling in adenomyosis revealed by LC-MS/MS profiling via openalex
- Tongmai Huazheng mixture attenuates adenomyosis by inducing ferroptosis through suppression of the JAK2/STAT3 signaling pathway via openalex
- Updates on adenomyosis and fertility via openalex
- Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations via openalex
- W7129261312 via openalex
- W7130568648 via openalex
- W7167743065 via openalex
- W7172441379 via openalex
- W4400723398 via openalex
- W1988477828 via openalex
- W2099928106 via openalex
- W2565616863 via openalex
- W2754394790 via openalex
- W2762087180 via openalex
- W2786275483 via openalex
- W2809281987 via openalex
- W2895487889 via openalex
- W3006900426 via openalex
- W3087201516 via openalex
- W3089739802 via openalex
- W3116557037 via openalex
- W3127491758 via openalex
- W3134167221 via openalex
- W3199852910 via openalex
- W4248078302 via openalex
- W4296688988 via openalex
- W4302362930 via openalex
- W4308695713 via openalex
- W4379619359 via openalex
- W4384930356 via openalex
- W4386099975 via openalex
- W4387310201 via openalex
- W4392886192 via openalex
- W1985458442 via openalex
- W4401833878 via openalex
- W4403912450 via openalex
- W4404046999 via openalex
- W4404704290 via openalex
- W4405923376 via openalex
- W4406824221 via openalex
- W4407483663 via openalex
- W4409602952 via openalex
- W4409732813 via openalex
- W4412621652 via openalex
- W4413011718 via openalex
- W4413033935 via openalex
- W4413432687 via openalex
- W4414418363 via openalex
- W4416384325 via openalex
- W7127365467 via openalex
Source provenance
- openalex
- last seen: 2026-11-22T06:06:27.128750+00:00
License: CC0
· commercial use OK